BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31857700)

  • 1. S100A4/non-muscle myosin II signaling regulates epithelial-mesenchymal transition and stemness in uterine carcinosarcoma.
    Tochimoto M; Oguri Y; Hashimura M; Konno R; Matsumoto T; Yokoi A; Kodera Y; Saegusa M
    Lab Invest; 2020 May; 100(5):682-695. PubMed ID: 31857700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperation of Sox4 with β-catenin/p300 complex in transcriptional regulation of the Slug gene during divergent sarcomatous differentiation in uterine carcinosarcoma.
    Inoue H; Takahashi H; Hashimura M; Eshima K; Akiya M; Matsumoto T; Saegusa M
    BMC Cancer; 2016 Feb; 16():53. PubMed ID: 26841870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional role of ALK-related signal cascades on modulation of epithelial-mesenchymal transition and apoptosis in uterine carcinosarcoma.
    Inoue H; Hashimura M; Akiya M; Chiba R; Saegusa M
    Mol Cancer; 2017 Feb; 16(1):37. PubMed ID: 28193280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleobindin-2 Mediates Transforming Growth Factor-β1-Driven Phenotypes in Zinc Finger E-Box Binding Homeobox 1-High Uterine Carcinosarcoma.
    Kobayashi Y; Yokoi A; Hashimura M; Oguri Y; Konno R; Matsumoto T; Tochimoto M; Nakagawa M; Ishibashi Y; Ito T; Ohhigata K; Harada Y; Fukagawa N; Kodera Y; Saegusa M
    Am J Pathol; 2023 Aug; 193(8):1116-1128. PubMed ID: 37169340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100A4/Nonmuscle Myosin IIA/p53 Axis Contributes to Aggressive Features in Ovarian High-Grade Serous Carcinoma.
    Hiruta A; Oguri Y; Yokoi A; Matsumoto T; Oda Y; Tomohiro M; Hashimura M; Jiang Z; Tochimoto M; Nakagawa M; Saegusa M
    Am J Pathol; 2020 Nov; 190(11):2304-2316. PubMed ID: 32805233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDAC Inhibition Induces Cell Cycle Arrest and Mesenchymal-Epithelial Transition in a Novel Pleural-Effusion Derived Uterine Carcinosarcoma Cell Line.
    Stockhammer P; Okumus Ö; Hegedus L; Rittler D; Ploenes T; Herold T; Kalbourtzis S; Bankfalvi A; Sucker A; Kimmig R; Aigner C; Hegedus B
    Pathol Oncol Res; 2021; 27():636088. PubMed ID: 34257602
    [No Abstract]   [Full Text] [Related]  

  • 7. Attenuation of cancer-initiating cells stemness properties by abrogating S100A4 calcium binding ability in head and neck cancers.
    Cheng LH; Hung KF; Huang TF; Hsieh HP; Wang SY; Huang CY; Lo JF
    Oncotarget; 2016 Nov; 7(48):78946-78957. PubMed ID: 27793047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A functional role of S100A4/non-muscle myosin IIA axis for pro-tumorigenic vascular functions in glioblastoma.
    Inukai M; Yokoi A; Ishizuka Y; Hashimura M; Matsumoto T; Oguri Y; Nakagawa M; Ishibashi Y; Ito T; Kumabe T; Saegusa M
    Cell Commun Signal; 2022 Apr; 20(1):46. PubMed ID: 35392912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between Trx-1 and S100P promotes colorectal cancer cell epithelial-mesenchymal transition by up-regulating S100A4 through AKT activation.
    Zuo Z; Zhang P; Lin F; Shang W; Bi R; Lu F; Wu J; Jiang L
    J Cell Mol Med; 2018 Apr; 22(4):2430-2441. PubMed ID: 29383839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing inter-component heterogeneity of biphasic uterine carcinosarcomas.
    Liu Y; Weber Z; San Lucas FA; Deshpande A; Jakubek YA; Sulaiman R; Fagerness M; Flier N; Sulaiman J; Davis CM; Fowler J; Starks D; Rojas-Espaillat L; Lazar AJ; Davies GE; Ehli EA; Scheet P
    Gynecol Oncol; 2018 Nov; 151(2):243-249. PubMed ID: 30194005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L1CAM expression in uterine carcinosarcoma is limited to the epithelial component and may be involved in epithelial-mesenchymal transition.
    Versluis M; Plat A; de Bruyn M; Matias-Guiu X; Trovic J; Krakstad C; Nijman HW; Bosse T; de Bock GH; Hollema H
    Virchows Arch; 2018 Nov; 473(5):591-598. PubMed ID: 30140948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis of the epithelial to mesenchymal transition in uterine carcinosarcoma.
    Osakabe M; Fukagawa D; Sato C; Sugimoto R; Uesugi N; Ishida K; Itamochi H; Sugiyama T; Sugai T
    Int J Gynecol Cancer; 2019 Feb; 29(2):277-281. PubMed ID: 30636710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-296 inhibits the metastasis and epithelial-mesenchymal transition of colorectal cancer by targeting S100A4.
    He Z; Yu L; Luo S; Li M; Li J; Li Q; Sun Y; Wang C
    BMC Cancer; 2017 Feb; 17(1):140. PubMed ID: 28209128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inversed Expression Patterns of S100A4 and E-Cadherin in Cervical Cancers: Implication in Epithelial-Mesenchymal Transition.
    Liu M; Liu J; Yang B; Gao X; Gao LL; Kong QY; Zhang P; Li H
    Anat Rec (Hoboken); 2017 Dec; 300(12):2184-2191. PubMed ID: 28921916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sonic hedgehog-Gli1 signaling pathway regulates the epithelial mesenchymal transition (EMT) by mediating a new target gene, S100A4, in pancreatic cancer cells.
    Xu X; Su B; Xie C; Wei S; Zhou Y; Liu H; Dai W; Cheng P; Wang F; Xu X; Guo C
    PLoS One; 2014; 9(7):e96441. PubMed ID: 25072505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of TGF-β signaling in uterine carcinosarcoma.
    Dwivedi SK; McMeekin SD; Slaughter K; Bhattacharya R
    Oncotarget; 2015 Jun; 6(16):14646-55. PubMed ID: 25918253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers.
    Lo JF; Yu CC; Chiou SH; Huang CY; Jan CI; Lin SC; Liu CJ; Hu WY; Yu YH
    Cancer Res; 2011 Mar; 71(5):1912-23. PubMed ID: 21169409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH.
    Gründker C; Bauerschmitz G; Schubert A; Emons G
    Int J Oncol; 2016 Jun; 48(6):2713-21. PubMed ID: 27098123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of S100A4 for bone metastasis in prostate cancer cells.
    Kim B; Jung S; Kim H; Kwon JO; Song MK; Kim MK; Kim HJ; Kim HH
    BMC Cancer; 2021 Feb; 21(1):137. PubMed ID: 33549040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100A4 promotes endometrial cancer progress through epithelial-mesenchymal transition regulation.
    Hua T; Liu S; Xin X; Cai L; Shi R; Chi S; Feng D; Wang H
    Oncol Rep; 2016 Jun; 35(6):3419-26. PubMed ID: 27109209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.